Fig. 2

Relative quantification of mRNA levels of CCL5, CXCL11 and CCL11. a No significant difference was found between any groups (P = 0.382, 0.390, 1.000 > 0.05, respectively). b Compared to normal controls, CXCL11 mRNA levels were increased in active ITP patients (P = 0.000 < 0.05). CXCL11 expression in responders was significantly reduced compared to active ITP, but still higher than controls (P = 0.000 < 0.05, respectively). c Compared to control, CCL11 mRNA levels in active ITP patients was reduced (P = 0.000 < 0.05), however, CCL11 mRNA levels improved in responders and was not significantly different from control (P = 1.000 > 0.05). * P < 0.01 vs control and responders, ^## P < 0.01 vs control